<< Read Full Article
<< Read Full Article
Sanofi Denies Pursuing ImClone
- Loading Comments...
Sanofi-Aventis(SNY Quote) said it doesn't have any plans to try to acquire biotech outfit ImClone(IMCL Quote).
The company made the comments to Reuters after a published report said it had been interested in pursuing the acquisition.
Sanofi-Aventis said it hasn't made a bid and doesn't intend to. ImClone said recently that it received a $36-a-share takeover proposal from a major pharmaceutical firm, but that director Carl Icahn wouldn't support the deal, leading the potential acquirer to walk away. ImClone didn't name the company. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,489.11 | 1,110.44 | 2,179.57 | 32.73 |
Oil *
79.42
|
|
UP
144.27
|
UP
14.81
|
UP
34.97
|
UP
0.72
|
10 Yr
3.27%
SPDR Gold
117.56
|
|
+1.39%
|
+1.35%
|
+1.63%
|
+2.25%
|
Data delayed 20 minutes |


Connect with TheStreet